By Donavyn Coffey
Anticoagulants continue to rank in the top three drug classes for avoidable adverse drug events. Safe application of these medications requires a nuanced approach, particularly in unique patient populations and cases of controversial use.
At the 2023 ACCP Annual Meeting, in Dallas, experts sought to dispel some of the controversies around thrombosis-related issues that pharmacists encounter. Above all, the presenters said it’s paramount that pharmacists consider every